OTCBB:LIXT

Lixte Biotechnology Holdings Stock Insider Trading

etoro logo Buy LIXT
*Your capital is at risk
$7.30
-0.180 (-2.41%)
At Close: Jun 23, 2026

Lixte Biotechnology Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 6.68. In total, the insiders bought 2.69M and sold 500K LIXT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
6.68
Buy 2.69M shares
Sell 500K shares
94% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 16, 2025
Buy
Common Stock
J-Other
Pursglove Geordan Garrett
CEO And Chairman Of The Board
CEO / President 0
Value: $0
Jun 16, 2025
Buy
Common Stock
J-Other
Pursglove Geordan Garrett
CEO And Chairman Of The Board
CEO / President 0
Value: $0
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Forman Stephen J.
Director
Director 5 851
Value: $7K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Brown Regina
Director
Director 9 508
Value: $11.5K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Yen Yun
Director
Director 8 777
Value: $10.6K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Bernards Rene
Director
Director 8 045
Value: $10K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Bernards Rene
Director
Director 8 045
Value: $10K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Yen Yun
Director
Director 8 777
Value: $10.6K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Brown Regina
Director
Director 9 508
Value: $11.5K
Mar 31, 2025
Buy
Options to Purchase Common Stock
A-Award
Forman Stephen J.
Director
Director 5 851
Value: $7K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Forman Stephen J.
Director
Director 3 030
Value: $7K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Yen Yun
Director
Director 4 545
Value: $10.6K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Brown Regina
Director
Director 4 924
Value: $11.5K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Bernards Rene
Director
Director 4 166
Value: $10K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Bernards Rene
Director
Director 4 166
Value: $10K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Brown Regina
Director
Director 4 924
Value: $11.5K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Yen Yun
Director
Director 4 545
Value: $10.6K
Jan 20, 2025
Buy
Options to Purchase Common Stock
A-Award
Forman Stephen J.
Director
Director 3 030
Value: $7K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Bernards Rene
Director
Director 5 304
Value: $7K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Forman Stephen J.
Director
Director 3 858
Value: $5K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Brown Regina
Director
Director 6 269
Value: $8K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Yen Yun
Director
Director 5 786
Value: $8K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Yen Yun
Director
Director 5 786
Value: $8K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Brown Regina
Director
Director 6 269
Value: $8K
Sep 30, 2024
Buy
Options to Purchase Common Stock
A-Award
Forman Stephen J.
Director
Director 3 858
Value: $5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Lixte Biotechnology Holdings
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at var...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE